Tarsus Pharmaceuticals Inc. (TARS)
NASDAQ · Healthcare
Tarsus Pharmaceuticals Inc. EPS 2020–2025
Tarsus Pharmaceuticals Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Tarsus Pharmaceuticals Inc. eps for the quarter ending March 31, 2026 was $0.16, a 75.00% decrease year-over-year.
- Tarsus Pharmaceuticals Inc. annual eps for 2025 was $1.59, a 48.21% decrease from 2024.
- Tarsus Pharmaceuticals Inc. annual eps for 2024 was $3.07, a 33.55% decrease from 2023.
- Tarsus Pharmaceuticals Inc. annual eps for 2023 was $4.62, a 83.33% increase from 2022.
- Tarsus Pharmaceuticals Inc. annual eps for 2022 was $2.52.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Tarsus Pharmaceuticals Inc. EPS — FAQ
Tarsus Pharmaceuticals Inc. (TARS) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Tarsus Pharmaceuticals Inc.'s eps?
Tarsus Pharmaceuticals Inc. (TARS) reported eps of $-1.59 for fiscal 2025.
Where can I see TARS's eps history?
The chart and table above show Tarsus Pharmaceuticals Inc.'s eps by year and by quarter, including the growth rate.